Featured TN Vaginal Rejuvenation Center
Laser Vaginal Rejuvenation Institute of Tennessee
501 19th St
Suite 701
Knoxville TN 37916
866-501-8347
About Laser Vaginal Rejuvenation Institute of Tennessee
Located in
Health News
Bernstein Liebhard LLP Reports On Upcoming FDA Meeting Seeking Input From Patients On Drug And Medical Device Regulatory Processes
Bernstein Liebhard LLP reports on the inaugural FDA Patient Network Annual Meeting to be held on May 18, 2012. The meeting will allow patients and advocates to discuss and review FDA drug and medical device regulatory processes.
New Study Links Blood Clot Risk to NuvaRing
According to the study published on May 10th 2012 in the British Medical Journal, non-oral contraceptives, including NuvaRing, have a higher risk of blood clots than combined oral contraceptives (COCs) based on oestrogens and progestins. NuvaRing, approved by the FDA in 2001, is a contraceptive that comes in the form of a vaginal ring using female hormones in an effort to prevent ovulation. Women who used a vaginal ring had a 6.5 times higher risk for developing blood clots compared to non-users of hormonal contraception. As of Dec. 31st 2011, approximately 950 lawsuits were pending, alleging injuries sustained from NuvaRing use, including some alleged deaths, heart attacks and strokes. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of NuvaRing severe adverse events. [ .
New Study Links Blood Clot Risk to NuvaRing
According to the study published on May 10th 2012 in the British Medical Journal, non-oral contraceptives, including NuvaRing, have a higher risk of blood clots than combined oral contraceptives (COCs) based on oestrogens and progestins. NuvaRing, approved by the FDA in 2001, is a contraceptive that comes in the form of a vaginal ring using female hormones in an effort to prevent ovulation. Women who used a vaginal ring had a 6.5 times higher risk for developing blood clots compared to non-users of hormonal contraception. As of Dec. 31st 2011, approximately 950 lawsuits were pending, alleging injuries sustained from NuvaRing use, including some alleged deaths, heart attacks and strokes. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of NuvaRing severe adverse events. [ .
Bernstein Liebhard Reports On The First Federal Vaginal Mesh Lawsuit Set For Trial
Bernstein Liebhard LLP reports on the first federal vaginal mesh lawsuit set for trial. The transvaginal mesh case is scheduled to be tried in federal court in West Virginia in February, 2013.

